CXCR4 and acute myeloid leukemia: Our analysis data suggested the predictive potential of CXCR as four CXCR members (CXCR3, CXCR4, CXCR5, and CXCR6) were significantly related to better clinical outcomes in HNSCC, as reported in acute myeloid leukemia [32].